+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B), Route of Administration (Intramuscular, Intravenous, Subcutaneous), Application, Distribution Channel - Forecast 2024-2030- Product Image
Global Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B), Route of Administration (Intramuscular, Intravenous, Subcutaneous), Application, Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B), Route of Administration (Intramuscular, Intravenous, Subcutaneous), Application, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887678
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Beta Interferon Market size was estimated at USD 3.44 billion in 2023, USD 3.62 billion in 2024, and is expected to grow at a CAGR of 5.83% to reach USD 5.11 billion by 2030.

Beta interferon is a type of protein that naturally occurs in the human body and plays an important role in the immune system, to fight off infections and diseases. It is classified as a cytokine, which means it is part of the signaling proteins widely used by the immune system to communicate between cells. It is used in the treatment of multiple sclerosis (MS), a debilitating neurological condition. Beta Interferon helps reduce inflammation and the frequency of relapses in MS patients, thereby modifying the disease course. The rising number of diagnosed MS cases globally drives demand for effective treatment options, boosting the market.

In addition, awareness programs and global health initiatives to spread knowledge about multiple sclerosis and its treatment options stimulate market demand. However, the side effects associated with beta interferon, such as flu-like symptoms, site reactions, and potential liver damage, may deter some patients from opting for this treatment. Moreover, ongoing research and development activities aimed at enhancing the efficacy and lowering the adverse effects of beta interferon preparations present promising opportunities for companies. Exploring novel therapeutic applications beyond multiple sclerosis and expanding into emerging economies with unmet medical needs present significant growth avenues for stakeholders in the beta interferon market.

Regional Insights

In the Americas, particularly in the United States and Canada, the beta interferon market is driven by the rising prevalence of MS, with patients seeking effective and safer therapies that can manage symptoms and delay disease progression. Recent patents in this region have focused on improvements in Beta Interferon formulations that enhance patient adherence by reducing the frequency of doses. Investments are also being channeled toward personalized medicine, which attempts to tailor treatments to the individual’s genetic composition, potentially increasing the efficacy of beta-interferon therapies.

At the same time, the EMEA market is diverse, with reimbursement policies varying significantly across countries, but they are generally favorable towards MS treatments. The European Medicines Agency (EMA) has proactively approved innovative dosing regimens and formulations that promise better outcomes or enhanced patient compliance. New patents in the region have aimed at reducing side effects associated with Beta Interferon, thereby improving the quality of life for patients. In the Asia Pacific region, the market for beta interferon is experiencing steady growth. This trend is largely driven by increasing awareness about MS and its symptoms, coupled with more comprehensive healthcare policies that are improving access to treatments. Countries such as China, Japan, and Australia are significant in the regional market due to their advanced healthcare systems and increasing investment in medical research.

Market Trends by Segment

  • Type: Utilization of interferon Beta-1A and Beta-1B as per their need in multiple sclerosis cases
  • Application: Increasing usage of beta interferon to treat immuno infectious diseases

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Roche Pharma India Introduces Ocrevus: A Novel Monoclonal Antibody for Multiple Sclerosis

Roche Pharma India, part of the global Swiss pharmaceutical conglomerate Roche, officially launched Ocrevus (ocrelizumab) in the Indian market, offering new hope to the 150,000-200,000 patients diagnosed with multiple sclerosis (MS) in the country. This biannual, two-hour infusion therapy marks a significant advancement over existing treatments by specifically targeting CD20+ B cells, which are implicated in the aggressive progression of MS by damaging the myelin sheath of nerve fibers.

Strategic Collaboration between Nona Biosciences and Boostimmune to Accelerate Cancer Therapy Innovations

Nona Biosciences entered a collaboration with Boostimmune, a company focused on advanced anti-cancer therapies. This partnership aims to utilize Nona Biosciences' proprietary Harbour Mice H2L2 platform, which produces fully human monoclonal antibodies, to develop cutting-edge Antibody-Drug Conjugates (ADCs) aimed at novel cancer targets. With its extensive experience in antibody discovery and development, Nona Biosciences supports projects from conception to Investigational New Drug (IND) application, ensuring a comprehensive integration of services to foster significant advancements in cancer treatment.

Key Company Profiles

The report delves into recent significant developments in the Beta Interferon Market, highlighting leading vendors and their innovative profiles. These include Amega Biotech, Avantor, Inc., Bayer AG, Biogen Inc., BioLegend, Inc. by PerkinElmer Inc., Biosidus S.A, F. Hoffmann La-Roche Ltd., Faron Pharmaceuticals, Heligenics, Inc., Merck KGaA, Novartis AG, OriGene Technologies, Inc., Pfizer Inc., Qiagen GmbH, Sino Biological, Inc., Synairgen PLC, Thermo Fisher Scientific Inc., and Xiamen Amoytop Biotech Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Beta Interferon Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of autoimmune diseases among population
5.1.1.2. Growing healthcare awareness and initiatives for immune disorders
5.1.1.3. Improved healthcare infrastructure and spending across economies
5.1.2. Restraints
5.1.2.1. Issues associated with ineffectiveness and high costs of beta interferon for some medical cases
5.1.3. Opportunities
5.1.3.1. Robust research activities to advanced individualized disease management for people living with multiple sclerosis
5.1.3.2. Development of technology-driven platforms for disease diagnosis
5.1.4. Challenges
5.1.4.1. Stringent and time consuming approval processes associated with beta interferon products
5.2. Market Segmentation Analysis
5.2.1. Type: Utilization of interferon Beta-1A and Beta-1B as per their need in multiple sclerosis cases
5.2.2. Application: Increasing usage of beta interferon to treat immuno infectious diseases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Beta Interferon Market, by Type
6.1. Introduction
6.2. Interferon Beta-1A
6.3. Interferon Beta-1B
7. Beta Interferon Market, by Route of Administration
7.1. Introduction
7.2. Intramuscular
7.3. Intravenous
7.4. Subcutaneous
8. Beta Interferon Market, by Application
8.1. Introduction
8.2. Antiviral Effects
8.3. Immunomodulatory Effects
9. Beta Interferon Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
10. Americas Beta Interferon Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Beta Interferon Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Beta Interferon Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Roche Pharma India Introduces Ocrevus: A Novel Monoclonal Antibody for Multiple Sclerosis
13.3.2. Strategic Collaboration between Nona Biosciences and Boostimmune to Accelerate Cancer Therapy Innovations
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. BETA INTERFERON MARKET RESEARCH PROCESS
FIGURE 2. BETA INTERFERON MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BETA INTERFERON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BETA INTERFERON MARKET DYNAMICS
FIGURE 7. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BETA INTERFERON MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. BETA INTERFERON MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BETA INTERFERON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BETA INTERFERON MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BETA INTERFERON MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BETA INTERFERON MARKET SIZE, BY ANTIVIRAL EFFECTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BETA INTERFERON MARKET SIZE, BY ANTIVIRAL EFFECTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BETA INTERFERON MARKET SIZE, BY IMMUNOMODULATORY EFFECTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BETA INTERFERON MARKET SIZE, BY IMMUNOMODULATORY EFFECTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. CANADA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 62. CANADA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 63. CANADA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. CANADA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 66. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 67. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. MEXICO BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 70. MEXICO BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 71. MEXICO BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 74. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. CHINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 106. CHINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 107. CHINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. CHINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. INDIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 114. INDIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 115. INDIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. INDIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 118. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 119. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. JAPAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 130. JAPAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 131. JAPAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. JAPAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 143. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 159. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 160. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 175. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. THAILAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 178. THAILAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 179. THAILAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. THAILAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 201. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. DENMARK BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 204. DENMARK BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 205. DENMARK BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. DENMARK BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 208. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 209. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. EGYPT BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 212. EGYPT BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 213. EGYPT BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. EGYPT BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 216. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 217. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. FINLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 220. FINLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 221. FINLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. FINLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. FRANCE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 228. FRANCE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 229. FRANCE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. FRANCE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 232. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 233. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. GERMANY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 236. GERMANY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 237. GERMANY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. GERMANY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 240. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 241. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. ITALY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 252. ITALY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 253. ITALY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. ITALY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 256. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 257. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 265. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. NORWAY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 276. NORWAY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 277. NORWAY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. NORWAY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 282. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 283. POLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 284. POLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 285. POLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. POLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 288. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 289. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 290. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 291. QATAR BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 292. QATAR BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 293. QATAR BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. QATAR BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 298. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 306. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 314. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 321. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 322. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 323. SPAIN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 324. SPAIN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 325. SPAIN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. SPAIN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 328. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 329. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 330. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 338. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 345. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 346. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 347. TURKEY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 348. TURKEY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 349. TURKEY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. TURKEY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 352. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES BETA INTER

Companies Mentioned

  • Amega Biotech
  • Avantor, Inc.
  • Bayer AG
  • Biogen Inc.
  • BioLegend, Inc. by PerkinElmer Inc.
  • Biosidus S.A
  • F. Hoffmann La-Roche Ltd.
  • Faron Pharmaceuticals
  • Heligenics, Inc.
  • Merck KGaA
  • Novartis AG
  • OriGene Technologies, Inc.
  • Pfizer Inc.
  • Qiagen GmbH
  • Sino Biological, Inc.
  • Synairgen PLC
  • Thermo Fisher Scientific Inc.
  • Xiamen Amoytop Biotech Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.11 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Global Interferon Market by Type (Alpha, Beta, Gamma), Category (Natural, Synthetic (Laboratory Made)), Distribution Channel, Application - Forecast 2024-2030 - Product Image

Global Interferon Market by Type (Alpha, Beta, Gamma), Category (Natural, Synthetic (Laboratory Made)), Distribution Channel, Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Beta Interferon - Global Strategic Business Report - Product Image

Beta Interferon - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Interferon - Global Strategic Business Report - Product Image

Interferon - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From
Interferons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Interferons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Global Interferons Market 2024-2028 - Product Image

Global Interferons Market 2024-2028

  • Report
  • 160 Pages
  • Global
From

About the Beta Interferon Market

Beta Interferon is a type of biotechnology drug used to treat multiple sclerosis (MS). It is a synthetic form of a naturally occurring protein that helps to reduce inflammation and slow the progression of MS. Beta Interferon is administered through injections and is used to reduce the frequency of MS relapses. It is also used to reduce the severity of symptoms and slow the progression of disability. Beta Interferon is one of the most widely used treatments for MS, and is often prescribed in combination with other therapies. It is also used to treat other neurological conditions, such as chronic inflammatory demyelinating polyneuropathy. The Beta Interferon market is highly competitive, with several major players offering a range of products. Companies in the market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.